- JP-listed companies
- KOBAYASHI PHARMACEUTICAL CO.,LTD.
- Balance sheet
KOBAYASHI PHARMACEUTICAL CO.,LTD.【JP:4967】Balance sheet
Market cap
¥428.3B
P/E ratio
38.9x
| 2014/03 | 2015/03 | 2016/03 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Cash and cash equivalents | - | 58,449 | 61,428 | 58,173 | 64,990 | 74,456 | 75,580 | 78,253 | 95,024 | 96,233 | 71,536 | 50,873 |
| Marketable securities, current | - | 4,500 | 4,500 | 5,500 | 8,300 | 8,300 | 14,977 | 16,085 | 14,022 | 8,300 | 8,300 | 14,872 |
| Accounts receivable, net | - | 35,969 | 36,088 | 47,045 | 50,032 | 53,386 | 54,818 | 52,850 | 55,169 | 47,881 | 53,028 | 49,442 |
| Inventories | - | 8,996 | 10,378 | 9,222 | 9,789 | 9,430 | 10,203 | 8,960 | 8,853 | 9,985 | 13,308 | 15,143 |
| Total current assets | - | 115,990 | 120,347 | 128,646 | 142,346 | 155,058 | 162,712 | 164,225 | 181,889 | 172,892 | 158,331 | 144,468 |
| Property, plant and equipment, net | - | 16,023 | 17,187 | 17,833 | 18,247 | 19,024 | 21,180 | 20,821 | 22,524 | 34,778 | 47,665 | 67,448 |
| Marketable securities, non-current | - | 41,580 | 39,656 | 40,281 | 46,797 | 45,916 | 39,533 | 34,474 | 29,466 | 28,509 | 32,124 | 24,617 |
| Total non-current assets | - | 70,340 | 68,650 | 72,587 | 76,484 | 75,930 | 70,685 | 74,141 | 70,664 | 82,934 | 109,142 | 120,900 |
| Total assets | - | 186,331 | 188,997 | 201,234 | 218,831 | 230,989 | 233,398 | 238,366 | 252,554 | 255,827 | 267,473 | 265,368 |
| Accounts payable | - | 10,239 | 7,141 | 8,169 | 8,279 | 8,706 | 8,276 | 7,558 | 9,293 | 9,051 | 8,745 | 8,264 |
| Short-term debt | - | 40 | 181 | 192 | 194 | 506 | 19 | 13 | 1 | - | - | - |
| Total current liabilities | - | 35,890 | 36,481 | 46,975 | 54,274 | 55,215 | 53,433 | 50,107 | 50,703 | 51,809 | 56,111 | 46,423 |
| Total non-current liabilities | - | 10,829 | 10,492 | 10,938 | 10,744 | 9,524 | 7,307 | 5,675 | 6,250 | 6,118 | 6,545 | 5,473 |
| Total liabilities | - | 46,720 | 46,974 | 57,914 | 65,019 | 64,740 | 60,740 | 55,783 | 56,954 | 57,927 | 62,656 | 51,896 |
| Common stock and paid-in capital | - | 7,669 | 8,403 | 8,408 | 7,633 | 7,633 | 7,633 | 7,633 | 7,633 | 3,972 | 3,972 | 3,972 |
| Retained earnings | - | 127,858 | 137,486 | 147,901 | 146,758 | 159,857 | 173,650 | 187,071 | 200,534 | 194,285 | 205,681 | 208,240 |
| Stockholders' equity | 126,953 | 139,611 | 142,023 | 143,320 | 153,811 | 166,249 | 172,657 | 182,583 | 195,600 | 197,900 | 204,816 | 213,471 |